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Background: Fluid retention caused by lower urinary sodium excretion may result in worse clinical outcomes in patients with heart failure 
(HF). However, the impact of urinary sodium excretion on the prognosis in patients with acute HF (AHF) remains unknown. In this study, we 
aim to investigate the association between sodium excretion, expressed as urinary sodium concentration (UNa) and clinical outcomes in 
patients with AHF.
methods: We examined 320 consecutive AHF patients who admitted to our institution between January 2013 and January 2014 from 
prospective registry. Baseline data including UNa in spot urinary sample were collected within 24 hours after admission. Patients with 
acute coronary syndrome and without complete data-set were excluded. Finally, 274 patients were divided into two groups according to the 
UNa level as follows; Group A [lowest tertile of UNa (UNa<74 mEq/l), n=89], Group B [middle and highest tertile of UNa (UNa≥74 mEq/l), 
n=185].
results: There were no significant differences between the groups in terms of age, sex, etiology of HF, cardiovascular medications, left 
ventricular ejection fraction (LVEF) and serum creatinine and brain natriuretic peptide (BNP) levels. Group A had lower serum sodium 
levels (138 vs 140 mEq/l, P<0.001) than group B. During follow-up period (median 218 days, IQR 125-334), there were 78 adverse events, 
including 20 death and 58 worsening HF. Kaplan-Meier analysis demonstrated that group A had higher incidence of adverse events 
than group B (Log-rank, P<0.001). In multivariate Cox proportional hazard modeling, lower UNa (UNa<74 mEq/l) was an independent 
determinant of adverse events (HR 2.3, 95% CI 1.3-4.1) among variables including age, sex, use of oral diuretics, serum creatinine and 
sodium, plasma BNP levels, and LVEF. Furthermore, plasma renin activity and aldosterone level on admission were significantly higher in 
group A than group B (8.6 vs 4.9 pg/dL: P<0.01, 17.0 vs 9.4 ng/dL: P<0.01, respectively).
conclusion:  Lower UNa on admission was an independent determinant for worse clinical outcomes with the higher renin-angiotensin-
aldosterone activity, suggesting it could be a potential prognostic marker in patients with AHF.
